IPOs, Initial Public Offerings: pre & post IPO

12 IPO reports & recommendations posted for Feb 3wk

Print this entry

SIGN up here.   Join our very active IPO user community & make better investment decisions.  You’ll also receive after-market recommendations.

Ranked in order of IPO size

  • Real estate finance, Ladder Capital (LADR)
  • Gypsum wallboard mfg, Continental Building Products (CBPX)
  • Closed end fund, CM Finance (CMFN)
  • Biopharma, Revance Therapeutics (RVNC)
  • Biotech, Genocea Biosciences (GNCA)
  • Gene therapy, uniQure B.V. (QURE)
  • Biopharma, Auspex Pharmaceuticals (ASPX)
  • Biopharma, Eleven Biotherapeutics (EBIO)
  • Biopharma, Argos Therapeutics (ARGS)
  • Specialty pharma, Egalet (EGLT)
  • Pharma, NephroGenex (NRX)
  • Cancer diagnostics, Biocept (BIOC)

Stifel Nicolas new analyst reports VNCE, SFXE, LULU, RH.  New coverage on NVGS.  Also CRTO, DSL, PAGP, ESNT, LEAF, BIND, FISH, ESPR, FLEX, SALE, EPAM, BFAM, COTY, ECOM, PF, RH, GTS, VOYA.  Available to paid subscribers.  Email your contact info,  name, mailing address (for compliance purposes) to Randy Hunt,  Senior Vice President/Investments, huntr@stifel.com


Leave a Reply



Lost your password?